Frontera Biotechnology SLU

Frontera collaborates in early projects evaluating novel therapeutic targets from academic groups or start-ups, managing pre-clinical and full developments. It also offers expertise in the generation of business plans, analysis of funding, organizational and operative designs, interim management, business development and legal and regulatory aspects of these developments. Frontera has worked with academic research centers as well for several companies in oncology and mental health, including the major oncology research center in Spain, such as CNIO (Centro Nacional de Investigaciones Oncológicas). In addition Frontera has participated in the creation of two new companies (Prokrea BCN and Glycoscience Biotechnology) for the development of treatments for infertility and for the use of a new group of natural and modified compounds with a wide range of therapeutic applications.